International Marijuana Business News

Health Canada: No ‘advance notice’ for new infused marijuana products allowed

Companies hoping to bypass or shorten the “60-day rule” requirement to notify Canadian regulators of new cannabis products will be out of luck, according to the country’s regulatory body. That’s going to give businesses more time to build up inventory and establish sales infrastructure – heading off some of the bottlenecks and distribution problems Canada saw […]

Read More

Canadian cannabis company warns about shady stock promotion

A small Canadian hemp cultivator is warning investors to be on the lookout for a “speculative” promotional email it says could be the cause of higher-than-average trading volume. The company – Toronto-based Two Hands Corp. – said it was unaware of the campaign promoting its company until it was notified by OTC Markets. Two Hands […]

Read More

Aurora Cannabis exec: ‘Having a major presence in US is nonnegotiable’

Aurora Cannabis is vowing to not be a spectator as rival Canopy Growth continues to plow hundreds of millions of dollars into high-growth U.S. CBD and medical marijuana markets. Aurora CCO Cam Battley told Jefferies analyst Owen Bennett that the Alberta company is closely watching developments in the United States. “Having a major presence in […]

Read More

Sale of locally grown cannabis, exports in Denmark expected as soon as summer

Five companies in Denmark have applied for licenses to sell and export medical cannabis so far, putting the country on track to see its first cross-border shipment to key European Union markets as early as late summer. Authorization to sell medical cannabis products cultivated and produced in Denmark is going to be key to lowering […]

Read More

White label cannabis products could play big role in Canada’s extracts market

Analysts anticipate that white label cannabis products – those manufactured by one company for branding and marketing by another – will play a key role in Canada’s cannabis extracts market, as companies look for ways to capitalize on the crucial segment without breaking the bank. Canada will allow the production and sale of marijuana edibles, extracts […]

Read More

Aphria prices $300M of convertible notes to fund global marijuana expansion

Canadian cannabis firm Aphria plans to raise capital via convertible senior notes in a private placement offering to fund international expansion initiatives and future acquisitions. Aphria priced $300 million of convertible senior notes due in 2024 for qualified institutional buyers, plus an option – exercisable within a 30-day period – for an additional $50 million, […]

Read More

Merrill Lynch launches marijuana sector coverage, predicts more cross-border deals

Bank of America Merrill Lynch deepened its interest in the cannabis industry by initiating coverage of the burgeoning sector, less than a year after it financed Constellation’s multibillion-dollar investment in Canada’s Canopy Growth. The report, by analyst Chris Carey, predicts two events may lead to a paradigm shift: Canada reaching marijuana oversupply by 2021. U.S. legalization. “Importantly, whether […]

Read More

Luxembourg’s medical cannabis program continues rapid implementation

Luxembourg’s medical marijuana program – approved in June 2018 – continues its fast-paced implementation, as 250 doctors have already completed the required training to prescribe the product. Roughly two-thirds of those doctors are generalists. Minister of Health Etienne Schneider provided the update in response to a parliamentary question from Martine Hansen, a member of Parliament […]

Read More

Canadian firms stockpile marijuana oil ahead of infused market launch

Canadian companies hoping to capitalize on the launch of new cannabis product categories later this year are building up inventories of marijuana oil – the key ingredient for those products – according to the latest data from Health Canada. Finished inventory of cannabis oil reached almost 60,000 liters through February, more than double the 28,000 […]

Read More